Literature DB >> 15956011

Weight loss in overweight adults and the long-term risk of hypertension: the Framingham study.

Lynn L Moore1, Agostino J Visioni, M Mustafa Qureshi, M Loring Bradlee, R Curtis Ellison, Ralph D'Agostino.   

Abstract

BACKGROUND: Few studies address long-term effects of weight loss on risk of incident hypertension among overweight adults.
METHODS: We evaluated weight loss among 623 overweight (body mass index [calculated as weight in kilograms divided by the square of height in meters] >/=25) middle-aged (aged 30-49 years) and 605 overweight older (aged 50-65 years) adults in Framingham, Mass. Subjects were classified first according to amount of weight lost over 4 years: (1) weight changed by less than 1.8 kg (stable weight), (2) lost 1.8 to less than 3.6 kg, (3) lost 3.6 to less than 6.8 kg, and (4) lost 6.8 kg or more. We also classified weight loss according to whether it was sustained during the next 4 years.
RESULTS: After adjusting for age, sex, education, baseline body mass index, height, activity, smoking, and alcohol intake, weight loss of 6.8 kg or more led to a 21% to 29% reduction in long-term hypertension risk. After adjusting for cancer or cardiovascular disease occurring during follow-up, weight loss of 6.8 kg or more led to a 28% reduction in risk (relative risk [95% confidence interval], 0.72 [0.49-1.05]) for middle-aged adults and a 37% reduction (0.63 [0.42-0.95]) for older adults. Sustained weight loss led to a 22% reduction in hypertension risk (0.78 [0.60-1.03]) among middle-aged and a 26% reduction (0.74 [0.56-0.97]) in older adults. This risk reduction was strengthened by adjustment for prevalent cancer or cardiovascular disease during follow-up.
CONCLUSION: A modest weight loss, particularly when sustained, substantially lowers the long-term risk of hypertension in overweight adults.

Entities:  

Mesh:

Year:  2005        PMID: 15956011     DOI: 10.1001/archinte.165.11.1298

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  29 in total

1.  Weight management and exercise: any advantage?

Authors:  George A Bray
Journal:  Am J Clin Nutr       Date:  2016-08-17       Impact factor: 7.045

2.  Initiation of sulfonylureas versus metformin is associated with higher blood pressure at one year.

Authors:  Christianne L Roumie; Xulei Liu; Neesha N Choma; Robert A Greevy; Adriana M Hung; Carlos G Grijalva; Marie R Griffin
Journal:  Pharmacoepidemiol Drug Saf       Date:  2012-03-19       Impact factor: 2.890

Review 3.  Cardiovascular Risk in Patients with Prehypertension and the Metabolic Syndrome.

Authors:  Sergey Kachur; Rebecca Morera; Alban De Schutter; Carl J Lavie
Journal:  Curr Hypertens Rep       Date:  2018-03-06       Impact factor: 5.369

4.  A prospective study of body mass index and the risk of developing hypertension in men.

Authors:  Rebecca P Gelber; J Michael Gaziano; JoAnn E Manson; Julie E Buring; Howard D Sesso
Journal:  Am J Hypertens       Date:  2007-04       Impact factor: 2.689

5.  The STEDMAN project: biophysical, biochemical and metabolic effects of a behavioral weight loss intervention during weight loss, maintenance, and regain.

Authors:  Lillian F Lien; Andrea M Haqq; Michelle Arlotto; Cris A Slentz; Michael J Muehlbauer; Ross L McMahon; James Rochon; Dianne Gallup; James R Bain; Olga Ilkayeva; Brett R Wenner; Robert D Stevens; David S Millington; Deborah M Muoio; Mark D Butler; Christopher B Newgard; Laura P Svetkey
Journal:  OMICS       Date:  2009-02

Review 6.  Benefit-risk paradigm for clinical trial design of obesity devices: FDA proposal.

Authors:  Herbert Lerner; Joyce Whang; Rebecca Nipper
Journal:  Surg Endosc       Date:  2012-12-18       Impact factor: 4.584

7.  Effect of 3-year weight history on blood pressure: the atherosclerosis risk in communities study.

Authors:  Kimberly P Truesdale; June Stevens; Jianwen Cai
Journal:  Obesity (Silver Spring)       Date:  2008-02-14       Impact factor: 5.002

8.  Weight loss during the intensive intervention phase of the weight-loss maintenance trial.

Authors:  Jack F Hollis; Christina M Gullion; Victor J Stevens; Phillip J Brantley; Lawrence J Appel; Jamy D Ard; Catherine M Champagne; Arlene Dalcin; Thomas P Erlinger; Kristine Funk; Daniel Laferriere; Pao-Hwa Lin; Catherine M Loria; Carmen Samuel-Hodge; William M Vollmer; Laura P Svetkey
Journal:  Am J Prev Med       Date:  2008-08       Impact factor: 5.043

9.  Blunted sympathoinhibitory responses in obesity-related hypertension are due to aberrant central but not peripheral signalling mechanisms.

Authors:  Jackie M Y How; Suhail A Wardak; Shaik I Ameer; Rachel A Davey; Daniela M Sartor
Journal:  J Physiol       Date:  2014-02-03       Impact factor: 5.182

10.  Bariatric Surgery to Correct Morbid Obesity Also Ameliorates Atherosclerosis in Patients with Type 2 Diabetes Mellitus.

Authors:  Yong Wang; Cuihua Zhang
Journal:  Am J Biomed Sci       Date:  2009-01-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.